Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Sundrug Co.,Ltd.
  6. News
  7. Summary
    9989   JP3336600006

SUNDRUG CO.,LTD.

(9989)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SUNDRUG CO LTD : Ex-dividend day for final dividend

03/27/2019 EDT
share with twitter
share with LinkedIn
share with facebook

A final dividend is removed today from Sundrug Co Ltd's share.



© Factset 2019
All news about SUNDRUG CO.,LTD.
03/30SUNDRUG CO.,LTD. : Ex-dividend day for final dividend
FA
02/10Sundrug Co.,Ltd. agreed to acquire Skinvill from I-ne CO., LTD..
CI
2021SUNDRUG CO.,LTD. : Ex-dividend day for interim dividend
FA
2021SUNDRUG CO.,LTD. : Ex-dividend day for final dividend
FA
2020SUNDRUG CO.,LTD. : Ex-dividend day for interim dividend
FA
2020SUNDRUG CO.,LTD. : Ex-dividend day for final dividend
FA
2019SUNDRUG CO LTD : Ex-dividend day for interim dividend
FA
2019SUNDRUG CO LTD : Ex-dividend day for final dividend
FA
2018SUNDRUG CO LTD : Ex-dividend day for interim dividend
FA
2018SUNDRUG CO LTD : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2022 650 B 5 086 M 5 086 M
Net income 2022 24 900 M 195 M 195 M
Net cash 2022 85 847 M 671 M 671 M
P/E ratio 2022 12,9x
Yield 2022 2,62%
Capitalization 319 B 2 494 M 2 494 M
EV / Sales 2022 0,36x
EV / Sales 2023 0,33x
Nbr of Employees 5 634
Free-Float 56,6%
Chart SUNDRUG CO.,LTD.
Duration : Period :
Sundrug Co.,Ltd. Technical Analysis Chart | 9989 | JP3336600006 | MarketScreener
Technical analysis trends SUNDRUG CO.,LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 2 727,00 JPY
Average target price 3 833,33 JPY
Spread / Average Target 40,6%
EPS Revisions
Managers and Directors
Hiroshi Sadakata Executive Officer & Manager-Sales II
Tatsuro Saitsu Director & Manager-Sales
Yoshinobu Kato Manager-Administration
Naoki Tada Director & General Manager-Administration
Nobuhiko Sugiura Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
SUNDRUG CO.,LTD.-9.25%2 494
COSMOS PHARMACEUTICAL CORPORATION-33.61%3 481
TSURUHA HOLDINGS INC.-38.41%2 582
SUGI HOLDINGS CO.,LTD.-24.53%2 543
LBX PHARMACY CHAIN JOINT STOCK COMPANY-26.45%2 421
KUSURI NO AOKI HOLDINGS CO., LTD.-24.14%1 364